Payden & Rygel Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$995K Sell
1,800
-1,100
-38% -$630K 0.08% 84
2024
Q1
$1.69M Buy
+2,900
New +$1.63M 0.08% 88
2023
Q3
$1.47M Buy
+2,900
New +$1.55M 0.1% 91

Other funds holding TMO

Payden & Rygel Investment Group's TMO Position: Q2 2024 in Review

Payden & Rygel Investment Group reduced its Thermo Fisher Scientific (TMO) stake by 38% in Q2 2024, selling an estimated $630K and leaving 1,800 shares worth $995K. The position accounts for 0.08% of the portfolio, ranked #84.

Payden & Rygel Investment Group first reported a position in TMO in Q3 2023 and has held it in 3 quarters since. The position peaked at $1.69M in Q1 2024. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Payden & Rygel Investment Group held 1,800 shares of Thermo Fisher Scientific worth $995K as of Q2 2024.
  • Payden & Rygel Investment Group sold 1,100 Thermo Fisher Scientific shares in Q2 2024, an estimated $630K.
  • Thermo Fisher Scientific made up 0.08% of Payden & Rygel Investment Group's portfolio in Q2 2024, its #84 holding.
  • Payden & Rygel Investment Group first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 3 quarters since.
  • Payden & Rygel Investment Group's Thermo Fisher Scientific position peaked at $1.69M in Q1 2024.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.